• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】62721

【品名】2-[1-(4-iodophenyl)ethyl]-4,4-dimethyl-4,5-dihydro-1,3-oxazole

【CA登记号】

【 分 子 式 】C13H16INO

【 分 子 量 】329.18065

【元素组成】C 47.43% H 4.9% I 38.55% N 4.26% O 4.86%

与该中间体有关的原料药合成路线共 1 条

合成路线1

该中间体在本合成路线中的序号:(LII)

The iodophenyl propionic acid (XLVIII) was protected as the oxazoline (LII) via activation as the corresponding acid chloride (XLIX), which was condensed with 2-amino-2-methylpropanol (L) to yield amide (LI). Subsequent cyclization of hydroxy amide (LI) by treatment with phosphorus oxychloride led to oxazoline (LII). Palladium coupling between aryl iodide (LII) and the Grignard reagent (VIII) provided the biaryl adduct (LIII). The oxazoline (LIII) was then hydrolyzed to (IX) with sulfuric acid and AcOH

2 Arai, H.; Tanaka, K.; Watanabe, I.; Kodama, T.; Hirano, H.; Abe, N.; Nakabayashi, M. (Toyama Chemical Co., Ltd.); Novel 2-[4-(3-methyl-2-thienyl)phenyl]propionic acid and pharmaceutically acceptable salt thereof and method for treating symptoms of inflammation and pain. US 4230719 .
1 Kodama, T.; Nakabayashi, M.; Watanabe, I.; Hirano, Y.; Abe, N.; Tanaka, K.; Arai, H. (Toyama Chemical Co., Ltd.); 2-[4-(3-Methyl-2-thienyl)phenyl]propionic acid derivs. and its non-toxic salts. DE 2850485; JP 1981049376 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VIII) 36973 bromo(3-methyl-2-thienyl)magnesium C5H5BrMgS 详情 详情
(IX) 62687 2-[4-(3-methyl-2-thienyl)phenyl]propanoic acid C14H14O2S 详情 详情
(XLVIII) 62718 2-(4-iodophenyl)propanoic acid C9H9IO2 详情 详情
(XLIX) 62719 2-(4-iodophenyl)propanoyl chloride C9H8ClIO 详情 详情
(L) 21513 2-amino-2-methyl-1-propanol;Karl Fischer;2-Amino-2-methyl-propan-1-ol;2-amino-2-methyl-1-propanol 124-68-5 C4H11NO 详情 详情
(LI) 62720 N-(2-hydroxy-1,1-dimethylethyl)-2-(4-iodophenyl)propanamide C13H18INO2 详情 详情
(LII) 62721 2-[1-(4-iodophenyl)ethyl]-4,4-dimethyl-4,5-dihydro-1,3-oxazole C13H16INO 详情 详情
(LIII) 62722 4,4-dimethyl-2-{1-[4-(3-methyl-2-thienyl)phenyl]ethyl}-4,5-dihydro-1,3-oxazole C18H21NOS 详情 详情
Extended Information